Publications

Search
Author [ Title(Desc)] Type Year
D
Abdelmoneim AS, Eurich DT, Gamble JM, Johnson JA, Seubert JM, Qiu W, et al. Diabetes, Obesity and Metabolism. Risk of acute coronary events associated with glyburide compared with gliclazide use in patients with type 2 diabetes: A nested case-control study [Internet]. 2014;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-84890569821&partnerID=MN8TOARS
Gamble J-M, Simpson SH, Eurich DT, Majumdar SR, Johnson JA. Diabetes, Obesity and Metabolism. Insulin use and increased risk of mortality in type 2 diabetes: A cohort study [Internet]. 2010;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-73349095732&partnerID=MN8TOARS
Gamble J-M, Donnan JR, Chibrikov E, Twells LK, Midodzi WK, Majumdar SR. Diabetes Research and Clinical Practice. The risk of fragility fractures in new users of dipeptidyl peptidase-4 inhibitors compared to sulfonylureas and other anti-diabetic drugs: A cohort study [Internet]. 2018;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85039789313&partnerID=MN8TOARS
Alkabbani W, Zongo A, Minhas-Sandhu JK, Eurich DT, Shah BR, Alsabbagh MW, et al. Diabetic Medicine. Five comparative cohorts to assess the risk of genital tract infections associated with sodium-glucose cotransporter-2 inhibitors initiation in type 2 diabetes mellitus [Internet]. 2022;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85129462097&partnerID=MN8TOARS
Abu-Ashour W, Chibrikova L, Midodzi WK, Twells LK, Gamble J-M. Diabetic Medicine. Factors associated with early insulin initiation in Type 2 diabetes: a Canadian cross-sectional study [Internet]. 2017;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-84959105986&partnerID=MN8TOARS
Abu-Ashour W, Chibrikova L, Midodzi WK, Twells LK, Gamble J-M. Diabetic Medicine. Factors associated with early insulin initiation in Type 2 diabetes: A Canadian cross-sectional study [Internet]. 2016;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-84959105986&partnerID=MN8TOARS
Eurich DT, Gamble JM, Marrie TJ, Majumdar SR. Diabetologia. Dysglycaemia and 90 day and 1 year risks of death or readmission in patients hospitalised for community-acquired pneumonia [Internet]. 2010;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-77949264220&partnerID=MN8TOARS
Dose response of sodium glucose cotransporter-2 inhibitors in relation to urinary tract infections: a systematic review and network meta-analysis of randomized controlled trials. CMAJ Open [Internet]. 2018;Available from: http://cmajopen.ca/content/6/4/E594.full Donnan et al. CMAJOpen 2018.pdf
Gamble J-M, Alkabbani W. Drug Safety. Author’s Reply to Kuss and Rathmann’s Comment on: “Drug-Drug Interaction of the Sodium Glucose Co-transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data” [Internet]. 2023;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85152556353&partnerID=MN8TOARS
Gamble J-M, Alkabbani W. Drug Safety. Authors’ Reply to Noguchi’s comment on: “Drug-Drug Interaction of the Sodium Glucose Co-transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data.” [Internet]. 2022;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85132201172&partnerID=MN8TOARS
Alkabbani W, Pelletier R, Beazely MA, Labib Y, Quan B, Gamble J-M. Drug Safety. Drug–Drug Interaction of the Sodium Glucose Co-Transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data [Internet]. 2022;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85125655701&partnerID=MN8TOARS
Alkabbani W, Pelletier R, Beazely MA, Labib Y, Quan B, Gamble J-M. Drug-Drug Interaction of the Sodium Glucose Co-Transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data. DRUG SAFETY. 2022;45:287-295.
Anand K, Sketris I, Zhang Y, Levy A, Gamble J-M. Drugs - Real World Outcomes. The Impact of US FDA and Health Canada Warnings Related to the Safety of High-dose Simvastatin [Internet]. 2017;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85047232099&partnerID=MN8TOARS
E
Pelletier R, Ng K, Alkabbani W, Labib Y, Mourad N, Gamble J-M. Endocrinology, Diabetes and Metabolism. The association of sodium-glucose cotransporter 2 inhibitors with cancer: An overview of quantitative systematic reviews [Internet]. 2020;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85084999654&partnerID=MN8TOARS
F
Alkabbani W, Zongo A, Minhas-Sandhu JK, Eurich DT, Shah BR, Alsabbagh MWasem, et al. Five comparative cohorts to assess the risk of genital tract infections associated with sodium-glucose cotransporter-2 inhibitors initiation in type 2 diabetes mellitus. DIABETIC MEDICINE. 2022;39:e14858.
H
Gamble J-M, Eurich DT, Johnson JA. Healthcare Policy. A comparison of drug coverage in Alberta before and after the introduction of the national common drug review process [Internet]. 2010;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-79851495266&partnerID=MN8TOARS
Maximos M, Pelletier R, Elsayed S, Maxwell CJ, Houle SKD, McConnell B, et al. Hospital Pharmacy. Unpacking Oral Challenge Protocols: A Descriptive Epidemiologic Study of Reactions, Predictors, and Practices for Delabeling Low-Risk Penicillin Allergies Leveraging Data from a Systematic Review and Meta-Analysis [Internet]. 2025;Available from: https://doi.org/10.1177/00185787251337626
I
Shakeri A, Dolovich L, MacCallum L, Gamble J-M, Zhou L, Cadarette SM. Impact of the 2016 Policy Change on the Delivery of MedsCheck Services in Ontario: An Interrupted Time-Series Analysis. Pharmacy (Basel). 2019;7(3).
Amegadzie JE, Gamble J-M, Farrell J, Gao Z. International Journal of COPD. Association between Inhaled β2-agonists Initiation and Risk of Major Adverse Cardiovascular Events: A Population-based Nested Case-Control Study [Internet]. 2022;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85131104214&partnerID=MN8TOARS
Amegadzie JE, Gamble J-M, Farrell J, Gao Z. International Journal of COPD. Gender differences in inhaled pharmacotherapy utilization in patients with obstructive airway diseases (OADS): A population-based study [Internet]. 2020;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85092135919&partnerID=MN8TOARS

Pages